These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. One view of the pathogenesis of sickle cell diseases. Charache S Bull Eur Physiopathol Respir; 1983; 19(4):361-6. PubMed ID: 6626767 [TBL] [Abstract][Full Text] [Related]
5. Complications of sickle cell disease. Walters I; Baysinger M; Buchanan I; Dahl JA; Dorn L; Finigan G; Luff J; Moore G; Myrie J; Noel C; Semper R Nurs Clin North Am; 1983 Mar; 18(1):139-84. PubMed ID: 6340072 [No Abstract] [Full Text] [Related]
6. New treatments for sickle cell disease. Med Lett Drugs Ther; 1973 Feb; 15(4):17-9. PubMed ID: 4695516 [No Abstract] [Full Text] [Related]
7. Cyanate as an inhibitor of red-cell sickling. Cerami A N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520 [No Abstract] [Full Text] [Related]
8. An adolescent with sickle cell anaemia experiencing disease-related complications: priapism and leg ulcer--a management challenge. Vasconcelos A; Prior AR; Ferrão A; Morais A BMJ Case Rep; 2012 Apr; 2012():. PubMed ID: 22605005 [TBL] [Abstract][Full Text] [Related]
14. [Sickle cell anemia. A review of clinical symptoms and therapy in adults]. Love RR; Kaboth W Med Klin; 1976 Nov; 71(48):2103-11. PubMed ID: 794664 [No Abstract] [Full Text] [Related]
15. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study. van Tuijn CFJ; Schimmel M; van Beers EJ; Nur E; Biemond BJ Am J Hematol; 2017 Oct; 92(10):E584-E590. PubMed ID: 28699283 [TBL] [Abstract][Full Text] [Related]